Government policies and regulations have created an environment hostile to research and innovation.
In most countries with universal health care, patients share the cost of treatment—surgical or pharmaceutical.
Every province in Canada has a prescription drug insurance program for low-income and vulnerable citizens.
There is no doubt that completion of negotiations for the Comprehensive Economic Trade Agreement (CETA), announced in October, is a major economic milestone for Canada. Gains of up to $12 billion a year are impressive and duty-free access for 98 per cent of Canadian goods to a market of 500 million people is a big deal.